News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Faster, More Accurate Cancer Treatments on Horizon in Japan With Official Approval of Elekta AB (SE:EKTAB)'s Agility Beam-shaping Innovation for Radiation Therapy



7/31/2012 10:15:03 AM

TOKYO--(BUSINESS WIRE)--Regulatory News: Following U.S. and European approvals of Elekta’s Agility (http://www.elekta.com/agility)™* MLC, Japan will join the international community of users of the beam-shaping device with the country’s PMDA clearance of Agility. The approval paves the way for the first clinical use of Agility in Japanese healthcare centers. Using a combination of 160 high-resolution tungsten leaves and dramatically faster leaf movement, Agility promises a new level of precision and delivery speed in radiation therapy treatments for patients with cancer.

Read at BioSpace.com


comments powered by Disqus
 
 

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES